Anna Wienner – General Manager, IBSA Hungary
Anna Wienner, general manager of IBSA Hungary, gives an update on the recent activities and achievement of the affiliate since her previous interview in 2016. Furthermore, Wienner goes on to…
Patent Ltd. was founded in 1989.
Our company mainly fabricates custom made stainless steel vessels for pharmaceutical, food and chemical industry. Beside that we have a serial production of special stainless steel structures for the energetics. To fulfill the needs of the the market, we are continuously improving our fabrication infrastructure.
Of course we are having the essential licenses for pressure vessel fabrications not only for Hungarian but also for the EU market. Our company has been qualified for the production of welded structures, pressure tanks and storage tanks of hazardous substances according to the requirements of DIN EN ISO 3834-2 / MSZ EN ISO 3834-2, AD 2000 Merkblatt HPO. We can fabricate according the requirements of 97/23/EK directive’s G; B1+F és B+F modul depending on the classification of the equipment. (PED)
We have a license to fabricate storage tanks for hazardous liquids and melts according to 11/1994 (III. 25.) IKM departmental order, and EN 15085 Railways Manufacturer’s Certificate.
And to be able to coordinate these special requirements we have established and introduced the MSZ EN ISO 9001-2008 quality assurance system.
Patent has relevant domestic and international experience, we are supplying a complex service from the design till the FAT (or till IQ, OQ). Depending the needs of our client the documentation we can supply in English, German or in Russian language.
Contact
2700 Cegléd, Bürgeházdűlő
Mail address: 2700 Cegléd, Pf.261
+36 30/439-0002
Anna Wienner, general manager of IBSA Hungary, gives an update on the recent activities and achievement of the affiliate since her previous interview in 2016. Furthermore, Wienner goes on to…
Norbert Langen, founder and CEO of Phytotec, a Hungarian distributor of evidence-based natural Rx and OTC drugs, introduces the company and its unique approach to marketing non-chemically formulated pharmaceuticals in…
Dr Ildikó Horvath, Hungary’s State Secretary for Health explains her role and shares insights on the key health trends in Hungary, the government’s top priority in improving healthcare, the importance…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
As the only one of Hungary’s four historical pharmaceutical manufactures to have resisted international acquisition, Gedeon Richter stands alone as the country’s national champion. However, the company does not exist…
Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the globe. As one of the four largest historical pharma companies…
Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its exciting new collaboration with Allergan in the US market, and the landmark launch of Gedeon’s…
Dr Péter Holchacker, director of the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM), shares his insights on the key activities of the organisation, the collaborations it fosters with authorities and…
Attila Lukács, general manager Hungary, Romania, Bulgaria for CSL Behring outlines emergent trends in the Hungarian plasma medication market, how the affiliate has succeeded in becoming a partner to patient…
Laszlo Dinca, managing director of Vanessa Research – Hungary, shares his insights on the company’s rare and orphan disease portfolio; the intentions behind the acquisition of Hungaro-Gal Pharmaceutical Manufacturing [HG…
Irma Veberic, general manager of Roche Hungary, gives her insights on the key issues being faced by the Hungarian healthcare system and the company’s role as a partner in improving…
István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning and digital biomarkers can revolutionize not only personalized oncology…
See our Cookie Privacy Policy Here
